Ovarian Fibrothecoma: A Residual Malignant Case

Authors

  • Ratri Wulandari Universitas Gadjah Mada, Yogyakarta
    Indonesia
  • Addin Trirahmanto Rumah Sakit Umum Pusat Dr. Sardjito, Yogyakarta
    Indonesia
  • Ardhanu Kusumanto Rumah Sakit Umum Pusat Dr. Sardjito, Yogyakarta
    Indonesia

DOI:

https://doi.org/10.23917/biomedika.v17i1.6668

Keywords:

Fibrothecoma, Malignant Neoplasm, Ovarian tumor

Abstract

Ovarian fibrothecomas, sex cord-stromal tumors consisting of theca-like elements and fibrous tissue, are solid tumors of the ovary, accounting for 1–4.7% of all ovarian tumors. If the tumors cannot be differentiated between fibroma and thecoma, they are categorized as fibrothecoma. These solid tumors are common, but their malignant type is extraordinarily rare. Here we present a residual malignant ovarian fibrothecoma in a 67-year-old woman. This patient complained of abdominal mass, she previously had laparotomy four times and two series of chemotherapy with paclitaxel and carboplatin within 19 years. Despite these, she currently has a residual disease measuring 13.5 x 11.6 x10.8 cm. In this case report, we will discuss the management of malignant fibrothecoma based on the available literature

Downloads

Download data is not yet available.

Downloads

Submitted

2024-09-17

Accepted

2025-05-21

Published

2025-02-10